AstraZeneca Divests Rights to Two Cardiovascular Drugs for $400 Million 0 30.10.2020 03:00 Feedity.com AstraZeneca is divesting two cardiovascular drugs to Germany’s Cheplapharm Arzneimittel GmbH for $400 million, which will allow the UK pharma giant to reinvest in its main therapy areas. Партнёры Smi24.net Все новости за 24 часа Музыкальные новости Агрегатор новостей 24СМИ
